My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 266

    1.

    The changing landscape of the clinical value of the PM/Scl autoantibody system.

    Mahler M, Fritzler MJ.

    Arthritis Res Ther. 2009;11(2):106. Epub 2009 Mar 26.PMID: 19351430 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.

    Brouwer R, Vree Egberts WT, Hengstman GJ, Raijmakers R, van Engelen BG, Seelig HP, Renz M, Mierau R, Genth E, Pruijn GJ, van Venrooij WJ.

    Arthritis Res. 2002;4(2):134-8. Epub 2001 Nov 12.PMID: 11879549 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.

    Schilders G, Egberts WV, Raijmakers R, Pruijn GJ.

    Arthritis Rheum. 2007 Jul;56(7):2449-54.PMID: 17599775 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.

    Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G.

    Arthritis Res Ther. 2009;11(1):R22. Epub 2009 Feb 16.PMID: 19220911 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.

    Mahler M, Raijmakers R.

    Autoimmun Rev. 2007 Aug;6(7):432-7. Epub 2007 Feb 20. Review.PMID: 17643929 [PubMed - indexed for MEDLINE]Related articles

    6.

    Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.

    Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA Jr.

    Arthritis Rheum. 1992 Oct;35(10):1211-7.PMID: 1418007 [PubMed - indexed for MEDLINE]Related articles

    7.

    Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients.

    Vandergheynst F, Ocmant A, Sordet C, Humbel RL, Goetz J, Roufosse F, Cogan E, Sibilia J.

    Clin Exp Rheumatol. 2006 Mar-Apr;24(2):129-33.PMID: 16762146 [PubMed - indexed for MEDLINE]Related articles

    8.

    PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.

    Raijmakers R, Renz M, Wiemann C, Egberts WV, Seelig HP, van Venrooij WJ, Pruijn GJ.

    Arthritis Rheum. 2004 Feb;50(2):565-9.PMID: 14872500 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?

    Mahler M, Fritzler MJ.

    Autoimmun Rev. 2009 Mar;8(5):373-8. Epub 2008 Dec 25. Review.PMID: 19103309 [PubMed - indexed for MEDLINE]Related articles

    10.

    The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma.

    Brouwer R, Pruijn GJ, van Venrooij WJ.

    Arthritis Res. 2001;3(2):102-6. Epub 2000 Dec 20. Review.PMID: 11178117 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.

    Schnitz W, Taylor-Albert E, Targoff IN, Reichlin M, Scofield RH.

    J Rheumatol. 1996 Oct;23(10):1729-33.PMID: 8895149 [PubMed - indexed for MEDLINE]Related articles

    12.

    Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.

    Reimer G, Scheer U, Peters JM, Tan EM.

    J Immunol. 1986 Dec 15;137(12):3802-8.PMID: 3537125 [PubMed - indexed for MEDLINE]Related articles

    13.

    Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.

    Cepeda EJ, Reveille JD.

    Curr Opin Rheumatol. 2004 Nov;16(6):723-32. Review.PMID: 15577611 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.

    Mahler M, Raijmakers R, Dähnrich C, Blüthner M, Fritzler MJ.

    Arthritis Res Ther. 2005;7(3):R704-13. Epub 2005 Apr 1.PMID: 15899056 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl.

    Marguerie C, Bunn CC, Copier J, Bernstein RM, Gilroy JM, Black CM, So AK, Walport MJ.

    Medicine (Baltimore). 1992 Nov;71(6):327-36.PMID: 1435228 [PubMed - indexed for MEDLINE]Related articles

    16.

    The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.

    Frank MB, McCubbin V, Trieu E, Wu Y, Isenberg DA, Targoff IN.

    J Autoimmun. 1999 Mar;12(2):137-42.PMID: 10047434 [PubMed - indexed for MEDLINE]Related articles

    17.

    Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.

    Mahler M, Greidinger EL, Szmyrka M, Kromminga A, Fritzler MJ.

    Ann N Y Acad Sci. 2007 Aug;1109:311-21.PMID: 17785320 [PubMed - indexed for MEDLINE]Related articles

    18.

    [PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis]

    Kim S, Genth E, Krieg T, Hunzelmann N.

    Z Rheumatol. 2005 Oct;64(7):499-502. German. PMID: 16244833 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Anti PM-Scl antibodies. Study of prevalence and of meaning]

    Gaudin C, Fortenfant F, Adoue D, Beyne-Rauzy O.

    Rev Med Interne. 2006 Sep;27(9):665-70. Epub 2006 Jun 12. French. PMID: 16797795 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk